Try our corporate solution for free!
(212) 419-8286

Select top biotech drugs based on revenue 2019

As of today, almost all of the world's top revenue generating drugs are derived from biotechnology and are part of the so called large molecule drugs. This statistic shows some of the best-selling biotech drugs worldwide over the last years, ranked by their sales in 2019. In that year, Enbrel generated a revenue of some 6.9 billion U.S. dollars combined for companies Amgen and Pfizer, and thus was still among world's top biotech drug based on sales.

Best-selling biotech drugs worldwide

AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 19.2 billion U.S. dollars and 7.1 billion U.S. dollars, respectively, in 2019. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 832 dedicated biotechnology companies in 2017. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 4 1billion U.S. dollars in biotech prescription drug revenues in 2019 and is expected to reach over 48 billion U.S. dollars in 2026. One of its top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2019. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.

The United States spent about 45 billion U.S. dollars on research and development in the biotechnology sector. The United States also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.

Select top selling biotech drugs worldwide in 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

September 2020



Survey time period


Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical biotech industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.